Roberts v. Commissioner of Social Security Administration

CourtDistrict Court, D. South Carolina
DecidedOctober 2, 2023
Docket1:23-cv-00786
StatusUnknown

This text of Roberts v. Commissioner of Social Security Administration (Roberts v. Commissioner of Social Security Administration) is published on Counsel Stack Legal Research, covering District Court, D. South Carolina primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Roberts v. Commissioner of Social Security Administration, (D.S.C. 2023).

Opinion

IN THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF SOUTH CAROLINA

Sandra A. R.,1 ) C/A No.: 1:23-786-SVH ) Plaintiff, ) ) vs. ) ) ORDER Kilolo Kijakazi, Acting ) Commissioner of Social Security ) Administration, ) ) Defendant. ) )

This appeal from a denial of social security benefits is before the court for a final order pursuant to 28 U.S.C. § 636(c), Local Civ. Rule 73.01(B) (D.S.C.), and the order of the Honorable Cameron McGowan Currie, United States District Judge, dated March 8, 2023, referring this matter for disposition. [ECF No. 6]. The parties consented to the undersigned United States Magistrate Judge’s disposition of this case, with any appeal directly to the Fourth Circuit Court of Appeals. [ECF No. 5]. Plaintiff files this appeal pursuant to 42 U.S.C. § 405(g) of the Social Security Act (“the Act”) to obtain judicial review of the final decision of the Commissioner of Social Security (“Commissioner”) denying the claim for disability insurance benefits (“DIB”). The two issues before the court are

1 The Committee on Court Administration and Case Management of the Judicial Conference of the United States has recommended that, due to significant privacy concerns in social security cases, federal courts should whether the Commissioner’s findings of fact are supported by substantial evidence and whether she applied the proper legal standards. For the reasons

that follow, the court affirms the Commissioner’s decision. I. Relevant Background A. Procedural History On May 3, 2019, Plaintiff filed an application for DIB in which she

alleged her disability began on April 19, 2019. Tr. at 369–75. Her application was denied initially and upon reconsideration. Tr. at 146–52, 154–59. Plaintiff had hearings by telephone before Administrative Law Judge (“ALJ”) Gregory M. Wilson on August 16, 2021, January 13, 2022, and July 21, 2022.

Tr. at 41–62, 63–74, 75–113 (Hr’g Tr.). The ALJ issued an unfavorable decision on August 17, 2022, finding that Plaintiff was not disabled within the meaning of the Act. Tr. at 8–33. Subsequently, the Appeals Council denied Plaintiff’s request for review, making the ALJ’s decision the final

decision of the Commissioner for purposes of judicial review. Tr. at 1–7. Thereafter, Plaintiff brought this action seeking judicial review of the Commissioner’s decision in a complaint filed on February 27, 2023. [ECF No. 1]. B. Plaintiff’s Background and Medical History 1. Background

Plaintiff was 58 years old at the time of the first hearing. Tr. at 86. She completed high school and some trade school. Tr. at 87. Her past relevant work (“PRW”) was as a laboratory technician. Tr. at 108. She alleges she has been unable to work since April 19, 2019. Tr. at 369.

2. Medical History Plaintiff presented to Augusta Mental Health (“AMH”) for an initial psychiatric evaluation on October 16, 2018. Tr. at 606–11. She reported a history of depressive symptoms since age 14 that included dysthymia,

hopelessness, helplessness, suicidal ideation, fragmented sleep, mood swings, labile affect, and periods of anxiety. Tr. at 606. Hany Elia, M.D. (“Dr. Elia”), recorded normal findings on mental status exam (“MSE”), aside from ambivalent and depressed mood. Tr. at 608–10. He assessed moderate major

depressive disorder (“MDD”) and generalized anxiety disorder (“GAD”). Tr. at 610–11. He discontinued Prozac, prescribed Lexapro 10 mg with a plan to increase it in two weeks if Plaintiff failed to improve, and continued Gabapentin. Tr. at 611.

Plaintiff followed up at AMH for medication management and a comprehensive nursing assessment on November 20, 2018. Tr. at 587–99. Dr. Elia noted Plaintiff’s Lexapro dose had been increased to 20 mg. Tr. at 613. Plaintiff reported doing well on prescribed medication with improved depression. Tr. at 596. The nurse recorded normal findings on MSE. Tr. at

596–99. Plaintiff reported neck pain and requested medication refills on February 27, 2019. Tr. at 627. Cynthia S. Murray, M.D. (“Dr. Murray”), assessed cervical neuralgia and continued Gabapentin 600 mg. Tr. at 628.

She indicated Plaintiff was doing well on medication for anxiety and refilled Lexapro 20 mg. Plaintiff presented to the emergency room (“ER”) at University Hospital on March 10, 2019. Tr. at 693. She indicated she had considered

overdosing on pills following an argument with her husband. Justin T. Geisler, M.D., observed depressed mood, suicidal ideation, and suicidal plans. Tr. at 695. He referred Plaintiff to Summit Ridge Hospital for inpatient care. Tr. at 698.

Plaintiff was hospitalized at Summit Ridge Hospital from March 11 to 15, 2019. Tr. at 753. She was diagnosed with severe bipolar disorder without psychosis and prescribed 10 mg of Lexapro and 150 mg of Trileptal in the morning and 300 mg of Trileptal in the evening.

Plaintiff returned to University Hospital for suicidal ideation with a plan to overdose on March 19, 2019. Tr. at 704. Andrew White, M.D., noted dysphoric mood and suicidal ideation on exam. Tr. at 706. He ordered that Plaintiff be transferred to a psychiatric facility for stabilization. Tr. at 708.

Plaintiff was hospitalized for suicidal ideation in the psychiatric unit at Peachford Hospital from March 20 to March 26, 2019. Tr. at 660. On admission, her appearance was disheveled, her mood was depressed and anxious, and her judgment and insight were significantly impaired. At the

time of discharge, she was calm, pleasant, and cooperative with no suicidal or homicidal ideation or auditory or visual hallucinations. Tr. at 661. The attending physician diagnosed MDD and prescribed Cymbalta 60 mg, Norvasc 5 mg, Zantac 150 mg, Trazodone 100 mg, and Neurontin 800 mg.

Plaintiff presented to licensed professional counselor Mary Clarkson (“Counselor Clarkson”) for a new patient evaluation on April 1, 2019. Tr. at 753–57. She reported Cymbalta had improved her mood, but Trazodone was ineffective and she was experiencing restless sleep. Tr. at 753. She indicated

she had recently taken Klonopin and had smoked marijuana the prior day. Tr. at 754. Counselor Clarkson noted dysphoric mood and fair insight and judgment, but otherwise normal findings on MSE. Tr. at 755. She assessed recurrent MDD without psychotic features and indicate a need to rule out

bipolar II disorder and borderline personality disorder. Tr. at 756. Physician assistant Stacia Fritz (“PA Fritz”) continued Cymbalta 60 mg, discontinued Trazodone, and added Doxepin 25 mg for sleep. Plaintiff presented to physician assistant Julie Buird (“PA Buird”) for acute anxiety on April 18, 2019. Tr. at 795. She described panic attacks

characterized by chest tightness, feeling nervous, and inability to focus. PA Buird assessed anxiety disorder and prescribed Klonopin 1 mg, twice a day as a needed for anxiety. Tr. at 797. Plaintiff presented to the ER at University Hospital following an

intentional overdose of Klonopin on April 21, 2019. Tr. at 715. Adam F. Hoover, M.D., observed Plaintiff to progress from initial lethargy to stupor with intermittent hypoxia, requiring Flumazenil to combat benzodiazepine overdose. Tr. at 717, 720. He indicated Plaintiff demonstrated slurred speech,

slowed behavior, depressed mood, inattentiveness, and suicidal ideation and plan. Tr. at 718. He discharged Plaintiff to inpatient psychiatric hospitalization. Tr. at 721. Plaintiff was hospitalized at Summit Ridge Hospital from April 22 to

April 29, 2019. Tr. at 738–42. At the time of intake, Plaintiff stated she had taken two Benadryl to sleep, but she had actually taken Ritalin and Klonopin in a suicidal attempt. Tr. at 740.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Richardson v. Perales
402 U.S. 389 (Supreme Court, 1971)
Heckler v. Campbell
461 U.S. 458 (Supreme Court, 1983)
Bowen v. Yuckert
482 U.S. 137 (Supreme Court, 1987)
Sullivan v. Zebley
493 U.S. 521 (Supreme Court, 1990)
Cichocki v. Astrue
729 F.3d 172 (Second Circuit, 2013)
Bonnilyn Mascio v. Carolyn Colvin
780 F.3d 632 (Fourth Circuit, 2015)
United States v. John Doe
810 F.3d 132 (Third Circuit, 2015)
Stacy Lewis v. Nancy Berryhill
858 F.3d 858 (Fourth Circuit, 2017)
Nikki Thomas v. Nancy Berryhill
916 F.3d 307 (Fourth Circuit, 2019)

Cite This Page — Counsel Stack

Bluebook (online)
Roberts v. Commissioner of Social Security Administration, Counsel Stack Legal Research, https://law.counselstack.com/opinion/roberts-v-commissioner-of-social-security-administration-scd-2023.